Drugs / BIIB041
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01597297 | Aug 2012 → Aug 2013 | multiple sclerosis | Biogen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIIB041 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01597297 ↗ |
| Route | Oral | “10 mg twice daily, given orally.” NCT01597297 ↗ |